News

Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...